These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11919736)

  • 1. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
    Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
    Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
    Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
    Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
    Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
    Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
    Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
    Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
    Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
    Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
    Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
    Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
    Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
    Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related, donor-derived AML responding to a second allogeneic BMT.
    Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM
    Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531
    [No Abstract]   [Full Text] [Related]  

  • 12. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
    Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
    Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation].
    Vinogradova OA; Savchenko VG; Domracheva EV; Liubimova LS; Ol'shanskaia IuV; Diachenko LV; Parovichnikova EN; Mendeleeva LP; Zakharova AV
    Ter Arkh; 2002; 74(7):38-44. PubMed ID: 12181833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation.
    Yong AS; Goldman JM
    Bone Marrow Transplant; 1999 Apr; 23(8):827-8. PubMed ID: 10231146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Santucci MA; Trabetti E; Martinelli G; Buzzi M; Zaccaria A; Pileri S; Farabegoli P; Sabattini E; Tura S; Pignatti PF
    Bone Marrow Transplant; 1992 Sep; 10(3):255-9. PubMed ID: 1422479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.
    Békássy AN; Hermans J; Gorin NC; Gratwohl A
    Bone Marrow Transplant; 1996 May; 17(5):801-8. PubMed ID: 8733701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
    O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
    Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT.
    Ditschkowski M; Haferlach C; Schulte C; Trenschel R; Beelen DW
    Bone Marrow Transplant; 2009 Aug; 44(4):265-6. PubMed ID: 19234516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.